- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Hepatology International
September 2019, Volume 13, Issue 5, pp 618–630 | Cite as
Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
Authors
Authors and affiliations
Yongcong YanYingjuan LuKai MaoMengyu ZhangHaohan LiuQianlei ZhouJianhong LinJianlong ZhangJie WangEmail authorZhiyu XiaoEmail author
Yongcong Yan
124
Yingjuan Lu
134
Kai Mao
124
Mengyu Zhang
5
Haohan Liu
124
Qianlei Zhou
124
Jianhong Lin
124
Jianlong Zhang
2
Jie Wang
2Email author
Zhiyu Xiao
2Email author
1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial HospitalSun Yat-Sen UniversityGuangzhouChina
2.Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial HospitalSun Yat-Sen UniversityGuangzhouChina
3.Department of Oral and Maxillofacial Surgery, Sun Yat-Sen Memorial HospitalSun Yat-Sen UniversityGuangzhouChina
4.RNA Biomedical Institute, Sun Yat-Sen Memorial HospitalSun Yat-Sen UniversityGuangzhouChina
5.Department of Gastroenterology and Hepatology, The First Affiliated HospitalSun Yat-Sen UniversityGuangzhouChina
Open Access
Original Article
First Online: 18 July 2019
1 Shares 474 Downloads 1 Citations
Abstract
Background
Hepatocellular carcinoma (HCC) is one of the most aggressive malignant tumors, with a poor long-term prognosis worldwide. The functional deregulations of global transcriptome were associated with the genesis and development of HCC, but lacks systematic research and validation.
Methods
A total of 519 postoperative HCC patients were included. We built an interactive and visual competing endogenous RNA network. The prognostic signature was established with the least absolute shrinkage and selection operator algorithm. Multivariate Cox regression analysis was used to screen for independent prognostic factors for HCC overall survival.
Results
In the training set, we identified a four-gene signature (PBK, CBX2, CLSPN, and CPEB3) and effectively predicted the overall survival. The survival times of patients in the high-score group were worse than those in the low-score group (p = 0.0004), and death was also more likely in the high-score group (HR 2.444, p < 0.001). The results were validated in internal validation set (p = 0.0057) and two external validation cohorts (HR 2.467 and 2.6). The signature (AUCs of 1, 2, 3 years were 0.716, 0.726, 0.714, respectively) showed high prognostic accuracy in the complete TCGA cohort.
Conclusions
In conclusion, we successfully built a more extensive ceRNA network for HCC and then identified a four-gene-based signature, enabling prediction of the overall survival of patients with HCC.
Keywords
Hepatocellular carcinoma Overall survival Competing endogenous RNA Least absolute shrinkage and selection operator Global transcriptome |
|